As of 2026-03-19, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 82.31 USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.44 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is 223.5%.
The range of the Relative Valuation is 21.39 - 158.18 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.0x - 25.3x | 22.6x |
| Forward P/E multiples | 21.9x - 26.5x | 24.1x |
| Fair Price | 21.39 - 158.18 | 82.31 |
| Upside | -15.9% - 521.8% | 223.5% |
| Date | P/E |
| 2026-03-17 | 4.23 |
| 2026-03-16 | 4.25 |
| 2026-03-13 | 4.16 |
| 2026-03-12 | 4.26 |
| 2026-03-11 | 4.37 |
| 2026-03-10 | 4.56 |
| 2026-03-09 | 4.50 |
| 2026-03-06 | 4.62 |
| 2026-03-05 | 4.73 |
| 2026-03-04 | 4.75 |
| 2026-03-03 | 5.29 |
| 2026-03-02 | 5.55 |
| 2026-02-27 | 5.57 |
| 2026-02-26 | 5.72 |
| 2026-02-25 | 5.55 |
| 2026-02-24 | 5.53 |
| 2026-02-23 | 5.49 |
| 2026-02-20 | 5.68 |
| 2026-02-19 | 5.87 |
| 2026-02-18 | 5.72 |
| 2026-02-17 | 5.69 |
| 2026-02-13 | 5.50 |
| 2026-02-12 | 5.48 |
| 2026-02-11 | 5.60 |
| 2026-02-10 | 5.55 |
| 2026-02-09 | 5.51 |
| 2026-02-06 | 5.47 |
| 2026-02-05 | 5.32 |
| 2026-02-04 | 5.60 |
| 2026-02-03 | 5.80 |
| 2026-02-02 | 5.77 |
| 2026-01-30 | 5.58 |
| 2026-01-29 | 5.63 |
| 2026-01-28 | 5.65 |
| 2026-01-27 | 5.97 |
| 2026-01-26 | 5.93 |
| 2026-01-23 | 5.92 |
| 2026-01-22 | 6.08 |
| 2026-01-21 | 6.03 |
| 2026-01-20 | 5.82 |
| 2026-01-16 | 6.00 |
| 2026-01-15 | 6.05 |
| 2026-01-14 | 6.27 |
| 2026-01-13 | 6.08 |
| 2026-01-12 | 6.40 |
| 2026-01-09 | 6.54 |
| 2026-01-08 | 7.13 |
| 2026-01-07 | 7.53 |
| 2026-01-06 | 6.93 |
| 2026-01-05 | 6.60 |